Reversing CD8+ T-cell exhaustion with DLI

Blood

Volumn 123, Issue 9, 2014, Pages 1289-1290

  Martin, Paul J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; CYTOKINE PRODUCTION; DONOR LYMPHOCYTE INFUSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; IMMUNOSTIMULATION; LEUKEMIA REMISSION; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STABLE EXPRESSION;

HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES, TUMOR-INFILTRATING; T-LYMPHOCYTES;

EID: 84897829724     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-01-547000     Document Type: Note

References (10)

1. Bachireddy P, Hainz U, Rooney M, et al. Reversal of in situ T-cell exhaustion during effective human anti-leukemia responses to donor lymphocyte infusion. Blood. 2014;123(9):1412-1421.
2. Kolb HJ, Mittermüller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76(12):2462-2465.
3. Kolb HJ, Schattenberg A, Goldman JM, et al European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86(5):2041-2050.
4. Collins RH Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15(2):433-444. (Pubitemid 27074209)
5. Giralt S, Hester J, Huh Y, et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 1995;86(11):4337-4343.
6. Alyea EP, Soiffer RJ, Canning C, et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood. 1998;91(10):3671-3680. (Pubitemid 28225734)
7. Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492-499.
8. + T cell exhaustion versus memory. Immunity. 2012;37(6):1130-1144.
9. Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10(1):29-37.
10. Saha A, Aoyama K, Taylor PA, et al. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. Blood. 2013;122(17):3062-3073.